× Close

Tuberculosis

Tuberculose, MSF, recherche opérationnelle
MSF nurse giving a training to a female MDR-TB patient in Matsanjeni health centre how to use Video Observed Therapy. Eswatini. May 2020. © Jakob Hein

    1. Abidi, S., Achar, J., Assao Neino, M., Bang, D., Benedetti, et.al., 2019. Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis. European Respiratory Journal, 55(3), p.1901467.
     

    2. Acquah, R. and Furin, J., 2019. Universal regimens or universal access to drug susceptibility testing for tuberculosis. The Lancet Infectious Diseases, 19(3), pp.224-225.
     

    3. Das, M., Pasupuleti, D., Rao, S., Sloan, S., Mansoor, et al., 2019. GeneXpert and Community Health Workers Supported Patient Tracing for Tuberculosis Diagnosis in Conflict-Affected Border Areas in India. Tropical Medicine and Infectious Disease, 5(1), p.1.
     

    4. de Vos, M., Ley, S., Wiggins, K., Derendinger, B., Dippenaar, A., et al., 2019. Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment. New England Journal of Medicine, 380(22), pp.2178-2180.
     

    5. Laxmeshwar, C., Stewart, A., Dalal, A., Kumar, A., Kalaiselvi, S., et al., 2019. Beyond ‘cure' and ‘treatment success': quality of life of patients with multidrug-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease, 23(1), pp.73-81.
     

    6. Loveday, M., Reuter, A., Furin, J., Seddon, J. and Cox, H., 2019. The STREAM trial: missed opportunities and lessons for future clinical trials. The Lancet Infectious Diseases, 19(4), pp.351-353.
     

    7. Mailu, E., Owiti, P., Ade, S., Harries, A., Manzi, M., et al., 2019. Tuberculosis control activities in the private and public health sectors of Kenya from 2013 to 2017: how do they compare?. Transactions of The Royal Society of Tropical Medicine and Hygiene, 113(12), pp.740-748.
     

    8. Mohr, E., Ferlazzo, G., Hewison, C., De Azevedo, V. and Isaakidis, P., 2019. Bedaquiline and delamanid in combination for treatment of drug-resistant tuberculosis. The Lancet Infectious Diseases, 19(5), p.470.
     

    9. Navya, N., Jeyashree, K., Madhukeshwar, A., Anand, T., Nirgude, A., et al., 2019. Are they there yet? Linkage of patients with tuberculosis to services for tobacco cessation and alcohol abuse – a mixed methods study from Karnataka, India. BMC Health Services Research, 19(1).
     

    10. Newtonraj, A., Venables, E., Selvaraj, K., Kundu, D., Purty, A., et al., 2019. Xpert negative means no TB: A mixed-methods study into early implementation of Xpert in Puducherry, India. Journal of Family Medicine and Primary Care, 8(4), p.1379.
     

    11. Quaglio, G., Pizzol, D., Isaakidis, P., Bortolani, A., Tognon, F., et al., 2019. Breast Tuberculosis in Women: A Systematic Review. The American Journal of Tropical Medicine and Hygiene, 101(1), pp.12-21.
     

    12. Reuter, A., Hughes, J. and Furin, J., 2019. Challenges and controversies in childhood tuberculosis. The Lancet, 394(10202), pp.967-978.